Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Screening is part of the standard evaluation process
Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
Mismanagement risk
This means any substance that: Is not approved by any governmental regulatory health authority for human therapeutic use (e.g., drugs under pre-clinical or clinical development)
Same molecule, different illness: the committee is weighing a use almost nobody is actually buying it for
US$ 23.76
US$ 27.19
US$ 21.66
US$ 26.05
